Effect of Add-on L-Arginine Therapy on Heart Failure Patients
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.
Also called NCT07394270
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT07394270
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07394270. Randomized; quadruple masking; primary purpose treatment. Start 2026-02 (anticipated); primary completion 2027-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Add-on L-Arginine Therapy on Heart Failure Patients
- Condition
- Heart Failure
- Intervention (Drug)
- L-Arginine Powder
- Intervention (Drug)
- Placebo
- Lead sponsor
- German University in Cairo
- Collaborator
- Ain Shams University
Record details
- Record id
cardio:ct-nct07394270- Content hash
27cee607cc54abb9d624d33e78a4dcbb3ac6cc867e41227eb9fb71bb52185041